A detailed history of Nwam LLC transactions in Pfizer Inc stock. As of the latest transaction made, Nwam LLC holds 54,912 shares of PFE stock, worth $1.63 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
54,912
Previous 53,209 3.2%
Holding current value
$1.63 Million
Previous $1.48 Million 4.07%
% of portfolio
0.45%
Previous 0.12%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$25.26 - $29.6 $43,017 - $50,408
1,703 Added 3.2%
54,912 $1.54 Million
Q1 2024

May 09, 2024

SELL
$25.89 - $29.73 $245,851 - $282,316
-9,496 Reduced 15.14%
53,209 $1.48 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $47,844 - $62,144
-1,831 Reduced 2.84%
62,705 $1.81 Million
Q3 2023

Oct 31, 2023

SELL
$32.09 - $37.51 $265,769 - $310,657
-8,282 Reduced 11.37%
64,536 $2.14 Million
Q2 2023

Aug 09, 2023

BUY
$36.12 - $41.79 $105,036 - $121,525
2,908 Added 4.16%
72,818 $2.67 Million
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $144,797 - $188,505
-3,676 Reduced 5.0%
69,910 $2.85 Million
Q4 2022

Feb 07, 2023

SELL
$41.75 - $54.5 $94,271 - $123,061
-2,258 Reduced 2.98%
73,586 $3.77 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $58,682 - $71,636
-1,341 Reduced 1.74%
75,844 $3.32 Million
Q2 2022

Aug 10, 2022

BUY
$46.53 - $55.17 $261,591 - $310,165
5,622 Added 7.86%
77,185 $3.99 Million
Q1 2022

May 12, 2022

BUY
$45.75 - $56.69 $198,555 - $246,034
4,340 Added 6.46%
71,563 $3.71 Million
Q4 2021

Feb 10, 2022

BUY
$41.32 - $61.25 $30,122 - $44,651
729 Added 1.1%
67,223 $3.97 Million
Q3 2021

Nov 03, 2021

BUY
$39.25 - $50.42 $36,620 - $47,041
933 Added 1.42%
66,494 $2.86 Million
Q2 2021

Aug 04, 2021

SELL
$35.91 - $40.68 $114,876 - $130,135
-3,199 Reduced 4.65%
65,561 $2.57 Million
Q1 2021

Apr 23, 2021

SELL
$33.49 - $37.77 $593,710 - $669,586
-17,728 Reduced 20.5%
68,760 $2.49 Million
Q4 2020

Jan 22, 2021

BUY
$33.47 - $42.56 $29,118 - $37,027
870 Added 1.02%
86,488 $3.18 Million
Q3 2020

Oct 16, 2020

SELL
$31.75 - $37.25 $185,928 - $218,136
-5,856 Reduced 6.4%
85,618 $3.14 Million
Q2 2020

Jul 21, 2020

BUY
$30.12 - $36.54 $1.03 Million - $1.25 Million
34,166 Added 59.62%
91,474 $2.99 Million
Q1 2020

Apr 16, 2020

SELL
$27.03 - $38.62 $317,872 - $454,171
-11,760 Reduced 17.03%
57,308 $1.87 Million
Q4 2019

Jan 23, 2020

BUY
$32.92 - $37.36 $276,857 - $314,197
8,410 Added 13.86%
69,068 $2.71 Million
Q3 2019

Oct 15, 2019

SELL
$32.49 - $42.13 $51,301 - $66,523
-1,579 Reduced 2.54%
60,658 $2.18 Million
Q2 2019

Jul 18, 2019

BUY
$36.98 - $41.52 $242,884 - $272,703
6,568 Added 11.8%
62,237 $2.7 Million
Q1 2019

Apr 17, 2019

SELL
$37.5 - $41.2 $19,575 - $21,506
-522 Reduced 0.93%
55,669 $2.36 Million
Q4 2018

Jan 30, 2019

BUY
$38.47 - $43.86 $53,011 - $60,439
1,378 Added 2.51%
56,191 $2.45 Million
Q3 2018

Oct 09, 2018

SELL
$34.47 - $41.81 $91,965 - $111,549
-2,668 Reduced 4.64%
54,813 $2.42 Million
Q2 2018

Jul 16, 2018

BUY
$32.98 - $35.16 $22,261 - $23,732
675 Added 1.19%
57,481 $2.09 Million
Q1 2018

Apr 16, 2018

SELL
$31.91 - $37.02 $20,805 - $24,137
-652 Reduced 1.13%
56,806 $2.02 Million
Q4 2017

Feb 07, 2018

BUY
$33.26 - $35.29 $98,083 - $104,070
2,949 Added 5.41%
57,458 $2.08 Million
Q3 2017

Nov 01, 2017

BUY
$31.0 - $34.15 $1.69 Million - $1.86 Million
54,509
54,509 $1.95 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Nwam LLC Portfolio

Follow Nwam LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nwam LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nwam LLC with notifications on news.